CROWLEY Richard 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 6, 2013
Insider Transaction Report
Form 4
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
- Sale
Common Stock $.01 par value per share
2013-02-04$1.01/sh−18,900$19,089→ 317,975 total - Sale
Common Stock $.01 par value per share
2013-02-04$1.05/sh−30,000$31,500→ 287,975 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 1, 2012.